Summary
A positive direct antiglobulin test (DAT) and hemolitic anemia are uncommon side effect of cisplatin (CDDP) therapy. A 9-year-old girl treated for extraosseus Ewing's sarcoma with a multiagent regimen, including 200 mg/m2 CDDP preceded by vincristine (VCR) and cyclophosphamide (CY), developed a posititve DAT, followed by hemolitic anemia. When CDDP therapy was discontinued, the DAT became negative and no signs of anemia were observed during the maintenance treatment, which included VCR and actinomycin D.
Similar content being viewed by others
References
Dini G, Lanino E, Rogers D, Garaventa A, Perin GP, Stura M, Dallorso S, Cornaglia-Ferraris P, De Bernardi B (1987) Resistant or relapsing neuroblastoma: improved response rate with a new multiagent regimen (OC-HDP) including “high dose” cis-platinum. Med Pediatr Oncol 15:18–23
Doll DG, Weiss RB (1985) Hemolytic anemia associated with antineoplastic agents. Cancer Treat Rep 69:777
Getaz EP, Becklex S, Fitzpatrick J, Dozier A (1980) Cisplatin-induced hemolysis. N Engl J Med 302:334
Levi JA, Aroney RS, Dalley DN (1981) Haemolytic anemia after cis-platin treatment. Br Med J [Clin Res] 282:2003
Nguyen BV, Jaffe N, Lichtiger B (1981) Cisplatin-induced anemia. Cancer Treat Rep 65:1121
Rubin H (1963) Antibody elution from red blood cells. J Clin Pathol 16:70
Tonini GP, Parodi MT, Bologna R, Persici P, Cornaglia-Ferraris P (1986) Cisplatin induces modulation of transferring receptor during cellular differentiation in vitro. Cancer Chemother Pharmacol 18:92
Williams CJ, Whitehouse JMA (1979) Cis-platinum: a new anticancer agent. Br Med J [Clin Res] 280:1689
Zwelling LA (1985) Cis-platin and new platinum analogs. In: Pinedo HM, Chabner BA (eds) Cancer chemotherapy, vol 7. Elsevier Science, Amsterdam, p 105
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cinollo, G., Dini, G., Franchini, E. et al. Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin. Cancer Chemother. Pharmacol. 21, 85–86 (1988). https://doi.org/10.1007/BF00262747
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00262747